The project "Construction of Innovative Peptide Library and Research and Development of Innovative Peptide Drugs" of Pingshan Center Incubator Enterprise Peptide Sheng Bio was successfully approved

The project "Construction of innovative peptide library and research and development of innovative peptide drugs" applied by Shenzhen Peptide Biotechnology Co., Ltd. (hereinafter referred to as "Peptide Bio"), an enterprise in the Shenzhen Bay Laboratory Pingshan Center Incubator, has been approved and supported by the Shenzhen Science and Technology Department.

Peptide Bio is a platform company focusing on peptide drug discovery. Based on the large-scale innovative complex structure peptide compound library under construction and the existing advanced high-throughput drug screening platform, Peptide Bio can provide screening and discovery services for active peptides, targeted transmembrane peptides, medical beauty active peptides, targeted delivery peptides and transdermal delivery peptides. At the same time, it can provide efficient sequence and structure optimization services, significantly shorten the time required for drug discovery and optimization, and can greatly promote the research and development of peptide drugs. The company has discovered a number of innovative peptide products that can be industrialized from the existing peptide library, including antibacterial peptides, instant anti-wrinkle peptides, etc.